EyeGene,Inc
Develops gene/cell therapies & mRNA vaccines for age-related and ocular diseases.
185490 | KO
Overview
Corporate Details
- ISIN(s):
- KR7185490000
- LEI:
- Country:
- South Korea
- Address:
- 경기도 의왕시 양지편2로 13 2층, 의왕시
- Website:
- https://eyegene.co.kr/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
EyeGene, Inc. is a clinical-stage biotechnology company focused on the research and development of innovative biopharmaceuticals. The company is pioneering gene and cell therapies to create transformative treatments for various conditions, with a historical focus on age-related and ocular diseases. Leveraging advanced technologies such as mRNA platforms and immunology, EyeGene develops a pipeline of novel therapeutics and vaccines. The company aims to become a global biopharmaceutical leader by advancing treatment and prevention through data-driven research to address unmet medical needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-17 00:00 |
Registration Form
증권신고서(지분증권) (2025.11)
|
Korean | 1.8 MB | ||
| 2025-09-16 00:00 |
Share Issue/Capital Change
주요사항보고서(유상증자결정)
|
Korean | 32.6 KB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.1 MB | ||
| 2025-06-30 00:00 |
Regulatory News Service
투자판단관련주요경영사항(임상시험계획승인신청등결정) (4가 수막구균 접합백신 ‘EGMCV4의 국내 임상 제2/3상 임상시…
|
Korean | 17.9 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.1 MB | ||
| 2025-05-12 00:00 |
Share Issue/Capital Change
주식매수선택권부여에관한신고
|
Korean | 18.1 KB | ||
| 2025-03-26 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 21.4 KB | ||
| 2025-03-18 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 26.5 KB | ||
| 2025-03-18 00:00 |
Annual Report
사업보고서 (2024.12)
|
Korean | 1.7 MB | ||
| 2025-03-11 00:00 |
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
|
Korean | 158.3 KB | ||
| 2025-03-10 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 159.1 KB | ||
| 2025-03-04 00:00 |
Regulatory News Service
투자판단관련주요경영사항(임상시험계획승인신청) (EGMCV4수막구균(혈청형 A, C, W135 및 Y군) 접합백신의 면역…
|
Korean | 12.1 KB | ||
| 2025-02-28 00:00 |
Legal Proceedings Report
투자판단관련주요경영사항(임상시험결과) (아이진 mRNA 기반 코로나19 예방백신 (EGCOVID) ‘이지코비드(EGC…
|
Korean | 14.5 KB | ||
| 2025-02-28 00:00 |
Regulatory News Service
투자판단관련주요경영사항(임상시험결과) (mRNA 기반 코로나19 예방 다가백신 이지코브투(EGCOVII) 호주 임상 제…
|
Korean | 14.9 KB | ||
| 2025-02-26 00:00 |
Legal Proceedings Report
투자판단관련주요경영사항(임상시험계획자진취하등) (4가 수막구균 접합백신 ‘EGMCV4의 국내 임상 3상 임상시험계획(I…
|
Korean | 11.1 KB |
Automate Your Workflow. Get a real-time feed of all EyeGene,Inc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for EyeGene,Inc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for EyeGene,Inc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
